The Patent Finder

Janssen Pharmaceutica N.V.

631 patents currently held · Updated Nov 18, 2026
173 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 39 name spellings.

Previously recorded as Janssen-Cilag S.A. (to 2010)

164
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 4 fees due Nov 23 to 26, 2026 · next Nov 23
  • 13 fees due Dec 6 to 30, 2026 · next Dec 6
  • 17 fees due Jan 4 to 30, 2027 · next Jan 4
  • 11 fees due Feb 6 to 25, 2027 · next Feb 6
  • 5 fees due Mar 1 to 26, 2027 · next Mar 1
  • 8 fees due Apr 1 to 30, 2027 · next Apr 1
  • 17 fees due May 3 to 28, 2027 · next May 3
  • 10 fees due Jun 12 to 30, 2027 · next Jun 12
  • 11 fees due Jul 5 to 30, 2027 · next Jul 5
  • 7 fees due Aug 6 to 27, 2027 · next Aug 6
  • 8 fees due Sep 1 to 19, 2027 · next Sep 1
  • 10 fees due Oct 2 to 30, 2027 · next Oct 2
  • 4 fees due Nov 5 to 14, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • 8 of the patents on this record were granted since Aug 20, 2026
  • 47 terms have ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,498,343Mycobacterial inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,531,671Dihydroisoindolones as allosteric modulators of glucokinase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,030,305Triazolopyridazines as kinase modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,834,025Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,119,650Aminophenyl derivatives as novel inhibitors of histone deacetylase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,163,765Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,078,896Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,101,616Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,947,830Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,888,360Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 631 patents shown.
Pro members see all 631.
Pro members: see all 631 patents
Also on record, not counted in the 631: 173 patents in force now held by others · 990 lapsed for an unpaid fee · 835 ended at full term · 3 past the fee grace period · 5 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

99 pending · 299 abandoned · 59 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited